GSK announced that North Carolina at enrollment reached new-activity
Public source
Company
GSK
- Industry
- Pharmaceutical Manufacturing
- Location
- London, GB
- Company size
- 10,001+ employees
About GSK
We are uniting science, technology and talent to get ahead of disease together. Our community guidelines: https://gsk.to/socialmedia
See moreLatest activity
Latest activity from GSK
39 signals
Presence & Recognition
GSK is attending the ERSCongress to meet global experts and shape the future of respiratory medicine with its pipeline targeting key inflammatory pathways of respiratory disease with longer-acting solutions.
Research & Knowledge
GSK published a new Custom Content article from The Wall Street Journal by Hesham A. Abdullah, MD, MSc and Chris Sheldon, PhD, sharing their approach to oncology business development.
Research & Knowledge
GSK accelerated research programmes are looking to target multiple inflammatory pathways, including TSLP and IL-33, to build a diverse portfolio for COPD patients.
Discover more
Similar signals
Similar public activity from other companies.
Strategy & Corporate Development
Sanofi
Sanofi announced that it will be the first company in the world to launch a new product line for the treatment of Alzheimer's disease.
Strategy & Corporate Development
Sandoz
Sandoz announced the Bio100 goal, aiming to build a portfolio of more than 100 biosimilars by 2040 and expand biosimilar loss-of-exclusivity coverage to 80% from 2035.
Strategy & Corporate Development
AstraZeneca
AstraZeneca launched its new Joint Declaration as part of the Speak Up for COPD coalition, outlining four priorities for timely and accurate diagnosis, equitable access to guideline-recommended treatment, integrated disease management and continuity of care, and COPD prevention and risk reduction.
Strategy & Corporate Development
Servier
Servier completed the acquisition of Edgewise Therapeutics’ Muscular Dystrophy Business to strengthen its commitment to rare neurological disorders and advance innovation for patients with Duchenne and Becker muscular dystrophies.
Strategy & Corporate Development
Almac Group